Gallium: a decisive "Trojan Horse" against microorganisms.
Gallium
Microorganisms
Mimetic effect
“Trojan Horse”
Journal
Antonie van Leeuwenhoek
ISSN: 1572-9699
Titre abrégé: Antonie Van Leeuwenhoek
Pays: Netherlands
ID NLM: 0372625
Informations de publication
Date de publication:
13 Sep 2024
13 Sep 2024
Historique:
received:
15
08
2022
accepted:
19
08
2024
medline:
13
9
2024
pubmed:
13
9
2024
entrez:
13
9
2024
Statut:
epublish
Résumé
Controlling multidrug-resistant microorganisms (MRM) has a long history with the extensive and inappropriate use of antibiotics. At the cost of these drugs being scarce, new possibilities have to be explored to inhibit the growth of microorganisms. Thus, metallic compounds have shown to be promising as a viable alternative to contain pathogens resistant to conventional antimicrobials. Gallium (Ga
Identifiants
pubmed: 39269546
doi: 10.1007/s10482-024-02015-2
pii: 10.1007/s10482-024-02015-2
doi:
Substances chimiques
Gallium
CH46OC8YV4
Iron
E1UOL152H7
Anti-Bacterial Agents
0
Anti-Infective Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Abdalla MY, Switzer BL, Goss CH, Aitken ML, Singh PK, Britigan BE (2015) Gallium compounds exhibit potential as new therapeutic agents against Mycobacterium abscessus. Antimicrob Agents Chemother 59:4826–4834. https://doi.org/10.1128/AAC.00331-15
doi: 10.1128/AAC.00331-15
pubmed: 26033732
pmcid: 4505262
Andrews SC, Robinson AK, Rodríguez-Quiñones F (2003) Bacterial iron homeostasis. FEMS Microbiol Rev 27:215–237. https://doi.org/10.1016/S0168-6445(03)00055-X
doi: 10.1016/S0168-6445(03)00055-X
pubmed: 12829269
Antunes LCS, Imcaoarivetperi F, Minandri F, Visca P (2012) In Vitro and in vivo antimicrobial activities of Gallium Nitrate against Multidrug-Resistant Acinetobacter baumannii. Antimicrob Agents Chemother 56:5961–5970. https://doi.org/10.1128/AAC.01519-12
doi: 10.1128/AAC.01519-12
pubmed: 22964249
pmcid: 3486561
Arivett BA, Fiester SE, Ohneck EJ, Penwell WF, Kaufman CM, Relich RF et al (2015) Antimicrobial activity of gallium protoporphyrin IX against Acinetobacter baumannii strains displaying different antibiotic resistance phenotypes. Antimicrob Agents Chemother 59:7657–7665. https://doi.org/10.1128/AAC.01472-15
doi: 10.1128/AAC.01472-15
pubmed: 26416873
pmcid: 4649216
Assis ASJ, Pegoraro GM, Duarte ICS (2022) Evolution of gallium applications in medicine and microbiology: a timeline. Biometals 35:675–688. https://doi.org/10.1007/s10534-022-00406-4
doi: 10.1007/s10534-022-00406-4
pubmed: 35729414
Bao G, Clifton M, Hoette TM, Mori K, Deng S et al (2010) Iron traffics in circulation bond to a siderocalin (Ngal)-catechol complex. Nat Chem Biol 6(8):602–609. https://doi.org/10.1038/nchembio.402
doi: 10.1038/nchembio.402
pubmed: 20581821
pmcid: 2907470
Bernstein LR (1998) Mechanisms of therapeutic activity for gallium. J Pharmacol Exp Ther 50:665–682
Best MG, Cunha-Reis C, Ganin AY, Sousa A, Johnston J, Oliveira AL et al (2020) Antimicrobial properties of Gallium(III)- and Iron(III)-loaded polysaccharides affecting the growth of Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa, in vitro. ACS Appl Bio Mater 3:7589–7597. https://doi.org/10.1021/acsabm.0c00811
doi: 10.1021/acsabm.0c00811
pubmed: 35019499
Bonchi C, Imperi F, Minandri F, Visca P, Frangipani E (2014) Repurposing of gallium-based drugs for antibacterial therapy: gallium-based antibacterials. BioFactors 40:303–312. https://doi.org/10.1002/biof.1159
doi: 10.1002/biof.1159
pubmed: 24532037
Bonchi C, Frangipani E, Imperi F, Visca P (2015) Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serum. Antimicrob Agents Chemother 59:5641–5646. https://doi.org/10.1128/AAC.01097-15
doi: 10.1128/AAC.01097-15
pubmed: 26149986
pmcid: 4538532
Bonifacio MA, Cometa S, Dicarlo M, Baruzzi F, de Candia S, Gloria A et al (2017) Gallium-modified chitosan/poly(acrylic acid) bilayer coatings for improved titanium implant performances. Carbohydr Polym 166:348–357. https://doi.org/10.1016/j.carbpol.2017.03.009
doi: 10.1016/j.carbpol.2017.03.009
pubmed: 28385242
Braun V, Killmann H (1999) Bacterial solutions to the iron-supply problem. Trends Biochem Sci 24:104–108. https://doi.org/10.1016/s0968-0004(99)01359-6
doi: 10.1016/s0968-0004(99)01359-6
pubmed: 10203757
Cao J, Woodhall MR, Alvarez J, Cartron ML, Andrews SC (2007) EfeUOB (YcdNOB) is a tripartite, acid-induced and CpxAR-regulated, low-pH Fe
doi: 10.1111/j.1365-2958.2007.05802.x
pubmed: 17627767
Celia H, Noinaj N, Zakharov SD, Bordignon E, Botos I, Santamaria M et al (2016) Structural insight into the role of the Ton Complex in energy transduction. Nature 538:60–65. https://doi.org/10.1038/nature19757
doi: 10.1038/nature19757
pubmed: 27654919
pmcid: 5161667
Cescau S, Cwerman H, Létoffé S, Delepelaire P, Wandersman C, Biville F (2007) Heme acquisition by hemophores. Biometals 20:603–613. https://doi.org/10.1007/s10534-006-9050-y
doi: 10.1007/s10534-006-9050-y
pubmed: 17268821
Chang D, Garcia R, Akers K, Mende K, Murray C, Wenke J et al (2016) Activity of gallium meso- and protoporphyrin IX against biofilms of multidrug-resistant Acinetobacter baumannii isolates. Pharmaceuticals 9:16. https://doi.org/10.3390/ph9010016
doi: 10.3390/ph9010016
pubmed: 26999163
pmcid: 4812380
Chitambar CR (2010) Medical applications and toxicities of gallium compounds. Int J Environ Rs Public Health 7:2337–2361. https://doi.org/10.3390/ijerph7052337
doi: 10.3390/ijerph7052337
Chitambar CR (2016) Gallium and its competing roles with iron in biological systems. Biochim Biophys Acta Mol Cell Res 1863:2044–2053. https://doi.org/10.1016/j.bbamrc.2016.04.027
doi: 10.1016/j.bbamrc.2016.04.027
Chitambar CR (2017) The therapeutic potential of iron-targeting gallium compounds in human disease: from basic research to clinical application. Pharmacol Res 115:56–64. https://doi.org/10.1016/j.phrs.2016.11.009
doi: 10.1016/j.phrs.2016.11.009
pubmed: 27856328
Choi S, Britigan BE, Moran DM, Narayanasamy P (2017) Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages. PLoS One 12:e0177987. https://doi.org/10.1371/journal.pone.0177987
doi: 10.1371/journal.pone.0177987
pubmed: 28542623
pmcid: 5436895
Choi S, Britigan BE, Narayanasamy P (2019a) Iron/heme metabolism-targeted gallium(III) nanoparticles are active against extracellular and intracellular Pseudomonas aeruginosa and Acinetobacter baumannii. Antimicrob Agents Chemother 5:1559–1569. https://doi.org/10.1128/AAC.02643-18
doi: 10.1128/AAC.02643-18
Choi S, Britigan BE, Switzer B, Hoke T, Moran D, Narayanasamy P (2018) In vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-tetraphenylporphyrine Against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice. Mol Pharmaceutics 15(3):1-32. https://doi.org/10.1021/acs.molpharmaceut.7b01036
doi: 10.1021/acs.molpharmaceut.7b01036
Choi S, Britigan BE, Narayanasamy P (2019b) Dual inhibition of Klebsiella pneumoniae and Pseudomonas aeruginosa iron metabolism using gallium porphyrin and gallium nitrate. ACS Infect Dis 5:1559–1569.
doi: 10.1021/acsinfecdis.9b00100
pubmed: 31264851
Clausen J, Edeling CJ, Fogh J (1974)
Coleman M, Kuskie K, Liu M, Chaffin K, Libal M, Giguère S, et al (2016) Corrigendum to: to: “In vitro antimicrobial activity of gallium maltolate against virulent Rhodococcus equi” [Vet Microbiol 2010;146:175–8]. Vet. Microbiol 146:175–178. https://doi.org/10.1016/j.vetmic.2010.05.027
Devireddy LR, Hart DO, Goetz D, Green MR (2010) A mammalian siderophore synthesized by an enzyme with a bacterial homologue involved in enterobactin production. Cell 141(6):1006–1017. https://doi.org/10.1016/j.cell.2010.04.040
doi: 10.1016/j.cell.2010.04.040
pubmed: 20550936
pmcid: 2910436
Dlouhy AC, Outten CE (2013) The iron metallome in eukaryotic organisms. Met Ions Life Sci 12:241–278. https://doi.org/10.1007/978-94-007-5561-1_8
doi: 10.1007/978-94-007-5561-1_8
pubmed: 23595675
pmcid: 3924584
Dong J, Fang D, Zhang L, Shan Q, Huang Y (2019) Gallium-doped titania nanotubes elicit anti-bacterial efficacy in vivo against Escherichia coli and Staphylococcus aureus biofilm. Materialia 5:100209. https://doi.org/10.1016/j.mtla.2019.100209
doi: 10.1016/j.mtla.2019.100209
Dudley HC, Imirie GW, Istock JT (1950) Deposition of Radiogallium (Ga72) in proliferating tissues. Radiology 55:571–578
doi: 10.1148/55.4.571
pubmed: 14781365
Fecteau M-E, Aceto HW, Bernstein LR, Sweeney RW (2014) Comparison of the antimicrobial activities of gallium nitrate and gallium maltolate against Mycobacterium avium subsp. paratuberculosis in vitro. Vet J 202:195–197. https://doi.org/10.1016/j.tvjl.2014.06.023
doi: 10.1016/j.tvjl.2014.06.023
pubmed: 25155307
Frangipani E, Bonchi C, Minandri F, Imperi F, Visca P (2014) Pyochelin potentiates the inhibitory activity of gallium on Pseudomonas aeruginosa. Antimicrob Agents Chemother 58:5572–5575. https://doi.org/10.1128/AAC.03154-14
doi: 10.1128/AAC.03154-14
pubmed: 24957826
pmcid: 4135843
Garcia RA, Tennent DJ, Chang D, Wenke JC, Sanchez CJ (2016) An in vitro comparison of PMMA and calcium sulfate as carriers for the local delivery of Gallium(III) Nitrate to staphylococcal infected surgical sites. BioMed Res Int 2016:7078989. https://doi.org/10.1155/2016/7078989
doi: 10.1155/2016/7078989
pubmed: 26885514
pmcid: 4739006
Goss CH, Kaneko Y, Khuu L, Anderson GD, Ravishankar S, Aitken ML et al (2018) Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections. Sci Transl Med 10:eaat7520. https://doi.org/10.1126/scitranslmed.aat7520
doi: 10.1126/scitranslmed.aat7520
pubmed: 30257953
pmcid: 6637966
Graves JL, Ewunkem AJ, Ward J, Staley C, Thomas MD, Rhinehardt KL et al (2019) Experimental evolution of gallium resistance in Escherichia coli. Evol Med Public Health 2019:169–180. https://doi.org/10.1093/emph/eoz025
doi: 10.1093/emph/eoz025
pubmed: 31890209
pmcid: 6928379
Große C, Scherer J, Koch D, Otto M, Taudte N, Grass G (2006) A new ferrous iron-uptake transporter, EfeU (YcdN), from Escherichia coli. Mol Microbiol 62:120–131. https://doi.org/10.1111/j.1365-2958.2006.05326.x
doi: 10.1111/j.1365-2958.2006.05326.x
pubmed: 16987175
Gugala N, Vu D, Parkins MD, Turner RJ (2019) Specificity in the susceptibilities of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus clinical isolates to six metal antimicrobials. Antibiotics 8:51. https://doi.org/10.3390/antibiotics8020051
doi: 10.3390/antibiotics8020051
pubmed: 31052359
pmcid: 6627307
Gunasekera SW, King LJ, Lavender PJ (1972) The behaviour of tracer gallium-67 towards serum proteins. Clin Chim Acta 39:401–406
doi: 10.1016/0009-8981(72)90059-9
pubmed: 4114559
Guo Y, Li W, Li H, Xia W (2019) Identification and characterization of a metalloprotein involved in Gallium internalization in Pseudomonas aeruginosa. ACS Infect Dis 5:1693–1697. https://doi.org/10.1021/acsinfecdis.9b00271
doi: 10.1021/acsinfecdis.9b00271
pubmed: 31475514
Harris WR, Pecoraro VL (1983) Thermodynamic binding constants for gallium transferrin. Biochemistry 22:292–299. https://doi.org/10.1021/bi00271a010
doi: 10.1021/bi00271a010
pubmed: 6402006
Hartman RE, Hayes RL (1969) The binding of gallium by blood serum. J Pharmacol Exp Ther 168:193–198
pubmed: 5792681
Hegge FN, Mahler DJ, Larson SM (1977) The incorporation of Ga-67 into the ferritin fraction of rabbit hepatocytes in vivo. J Nucl Med 18:937–939
pubmed: 893795
He X, Han B, Wang R, Guo Y, Kao RYT, Li H et al (2023) Dual-action gallium-flavonoid compounds for combating Pseudomonas aeruginosa infection. RSC Chem Biol 4:774–784. https://doi.org/10.1039/D3CB00033H
doi: 10.1039/D3CB00033H
pubmed: 37799578
pmcid: 10549236
Hijazi S, Visaggio D, Pirolo M, Frangipani E, Bernstein L, Visca P (2018) Antimicrobial activity of gallium compounds on ESKAPE pathogens. Front Cell Infect Microbiol 8: 316
doi: 10.1016/j.jtemb.2017.01.006
pubmed: 30250828
pmcid: 6139391
Hijazi S, Visca P, Frangipani E (2017) Gallium-Protoporphyrin IX Inhibits Pseudomonas aeruginosa Growth by Targeting Cytochromes. Front cell infect microbiol 7:1-12. https://doi.org/10.3389/fcimb.2017.00012
doi: 10.3389/fcimb.2017.00012
Huayhuaz JAA, Vitorino HA, Campos OS, Serrano SHP, Kaneko TM, Espósito BP (2017) Desferrioxamine and desferrioxamine-caffeine as carriers of aluminum and gallium to microbes via the Trojan Horse effect. J Trace Elem Med Biol 41:16–22. https://doi.org/10.1016/j.jtemb.2017.01.006
doi: 10.1016/j.jtemb.2017.01.006
pubmed: 28347458
Hubert J, Khayam-Bashi H (1977) The association of Ga-67 and lactoferrin. J Nucl Med 18:713–7
doi: 10.1016/j.jtemb.2017.01.006
Kammler M, Schon C, Hantke K (1993) Characterization of the ferrous iron uptake system of Escherichia coli. J Bacteriol 175:6212–6219. https://doi.org/10.1128/jb.175.19.6212-6219.1993
doi: 10.1128/jb.175.19.6212-6219.1993
pubmed: 8407793
pmcid: 206716
Kaneko Y, Thoendel M, Olakanmi O, Britigan BE, Singh PK (2007) The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J Clin Invest 117:877–888. https://doi.org/10.1172/JCI30783
doi: 10.1172/JCI30783
pubmed: 17364024
pmcid: 1810576
Kaplan CD, Kaplan J (2009) Iron acquisition and transcriptional regulation. Chem Rev 109(10):4536–4552. https://doi.org/10.1021/cr9001676
doi: 10.1021/cr9001676
pubmed: 19705827
Killmann H, Benz R, Braun V (1993) Conversion of the FhuA transport protein into a diffusion channel through the outer membrane of Escherichia coli. EMBO J 12:3007–3016
doi: 10.1002/j.1460-2075.1993.tb05969.x
pubmed: 7688295
pmcid: 413565
Krewulak KD, Vogel HJ (2008) Structural biology of bacterial iron uptake. Biochim Biophys Acta Biomembr 1778:1781–1804. https://doi.org/10.1016/j.bbamem.2007.07.026
doi: 10.1016/j.bbamem.2007.07.026
Kumar VB, Natan M, Jacobi G, Porat Z, Banin E, Gedanken A (2017) Ga@C-dots as an antibacterial agent for the eradication of Pseudomonas aeruginosa. IJN 12:725–730
doi: 10.2147/IJN.S116150
pubmed: 28176980
pmcid: 5271377
Kurtjak M, Vukomanović M, Kramer L, Suvorov D (2016) Biocompatible nano-gallium/hydroxyapatite nanocomposite with antimicrobial activity. J Mater Sci Mater Med 27:170. https://doi.org/10.1007/s10856-016-5777-3
doi: 10.1007/s10856-016-5777-3
pubmed: 27704374
Lau CKY, Krewulak KD, Vogel HJ (2015) Bacterial ferrous iron transport: the Feo system. FEMS Microbiol Rev 40:273–298. https://doi.org/10.1093/femsre/fuv049
doi: 10.1093/femsre/fuv049
pubmed: 26684538
Lindgren H, Sjöstedt A (2016) Gallium potentiates the antibacterial effect of gentamicin against Francisella tularensis. Antimicrob Agents Chemother 60:288–295. https://doi.org/10.1128/AAC.01240-15
doi: 10.1128/AAC.01240-15
pubmed: 26503658
Lin Z, Gao C, Wang D, He Q (2021) Bubble-propelled Janus gallium/zinc micromotors for the active treatment of bacterial infections. Angew Chem Int 60:8750–8754. https://doi.org/10.1002/anie.202016260
doi: 10.1002/anie.202016260
Logan KJ, Ng PK, Turner CJ, Schmidt RP, Terner UK, Scott JR et al (1981) Comparative pharmacokinetics of
doi: 10.1016/0047-0740(81)90033-4
pubmed: 6948783
Madigan MT, Martinko JM, Bender KS, Buckley DH, Stahl DA (2016) Brock biology of microorganisms, fourteenth. Pearson Education, Boston
Mendeleev D (1871) The natural system of elements and its application to the indication of the properties of undiscovered elements. J Russ Chem Soc 3:25–56
Miethke M, Marahiel MA (2007) Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev 71:413–451. https://doi.org/10.1128/MMBR.00012-07
doi: 10.1128/MMBR.00012-07
pubmed: 17804665
pmcid: 2168645
Mjos KD, Cawthray JF, Polishchuk E, Abrams MJ, Orvig C (2016) Gallium(III) and Iron(III) complexes of quinolone antimicrobials. Dalton Trans 45:13146–13160
doi: 10.1039/C6DT01315E
pubmed: 27315225
Morales-de-Echegaray AV, Maltais TR, Lin L, Younis W, Kadasala NR, Seleem MN et al (2018) Rapid uptake and photodynamic inactivation of Staphylococci by Ga(III)-Protoporphyrin IX. ACS Infect Dis 4:1564–1573. https://doi.org/10.1021/acsinfecdis.8b00125
doi: 10.1021/acsinfecdis.8b00125
pubmed: 30175917
pmcid: 6724182
Morales-de-Echegaray AV, Lin L, Sivasubramaniam B, Yermembetova A, Wang Q, Abutaleb NS et al (2020) Antimicrobial photodynamic activity of gallium-substituted haemoglobin on silver nanoparticles. Nanoscale 12:21734–21742. https://doi.org/10.1039/C9NR09064A
doi: 10.1039/C9NR09064A
pubmed: 33094755
pmcid: 7663423
Neill CJ, Harris S, Goldstone RJ, Lau ECHT, Henry TB, Yiu HHP et al (2020) Antibacterial activities of Ga(III) against E. Coli are ubstantially impacted by Fe(III) uptake systems and multidrug resistance in combination with oxygen levels. ACS Infect Dis 6:2959–2969. https://doi.org/10.1021/acsinfecdis.0c00425
doi: 10.1021/acsinfecdis.0c00425
pubmed: 32960047
Nikaido H (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67:593–656. https://doi.org/10.1128/MMBR.67.4.593-656.2003
doi: 10.1128/MMBR.67.4.593-656.2003
pubmed: 14665678
pmcid: 309051
Norman TE, Batista M, Lawhon SD, Zhang S, Kuskie KR, Swinford AK, Bernstein LR, Cohen ND (2014) In vitro susceptibility of equine-obtained isolates of Corynebacterium pseudotuberculosis to gallium maltolate and 20 other antimicrobial agents. J Clin Microbiol 52:2684–2685. https://doi.org/10.1128/JCM.01252-14
doi: 10.1128/JCM.01252-14
pubmed: 24829243
pmcid: 4097677
Orlean P, Pringle JR, Broach JR, Jones EW (1997) The molecular and cellular biology of the yeast Saccharomyces. In: Cell cycle and cell biology, vol 229. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, p 362
Pandey A, Savino C, Ahn SH, Yang Z, Van Lanen SG, Boros E (2019) Theranostic gallium siderophore ciprofloxacin conjugate with broad spectrum antibiotic potency. J Med Chem 62:9947–9960. https://doi.org/10.1021/acs.jmedchem.9b01388
doi: 10.1021/acs.jmedchem.9b01388
pubmed: 31580658
pmcid: 6943944
Philpott CC (2006) Iron uptake in fungi: a system for every source. BBA-Mol Cell Res 1763(7):636–645. https://doi.org/10.1016/j.bbamcr.2006.05.008
doi: 10.1016/j.bbamcr.2006.05.008
Piatek M, Griffith D, Kavanagh K (2020) Quantitative proteomic reveals gallium maltolate induces an iron-limited stress response and reduced quorum-sensing in Pseudomonas aeruginosa. J Biol Inorg Chem 25:1153–1165. https://doi.org/10.1007/s00775-020-01831-x
doi: 10.1007/s00775-020-01831-x
pubmed: 33125529
Ramos JL (2004) Pseudomonas. Springer US, Boston, MA
doi: 10.1007/978-1-4419-9088-4
Rasey JS, Nelson NJ, Larson SM (1982) Tumor cell toxicity of stable gallium nitrate: enhancement by transferrin and protection by iron. Eur J Cancer Clin Oncol 18:661–668. https://doi.org/10.1016/0277-5379(82)90212-7
doi: 10.1016/0277-5379(82)90212-7
pubmed: 6889967
Ratledge C, Dover LG (2000) Iron metabolism in pathogenic bacteria. Annu Rev Microbiol 54:881–941. https://doi.org/10.1146/annurev.micro.54.1.881
doi: 10.1146/annurev.micro.54.1.881
pubmed: 11018148
Rice LB (2010) Progress and challenges in implementing the research on ESKAPE pathogens. Infect Cont Hosp Ep 31:S7–S10. https://doi.org/10.1086/655995
doi: 10.1086/655995
Richter K, Thomas N, Zhang G, Prestidge CA, Coenye T, Wormald P-J et al (2017) Deferiprone and gallium-protoporphyrin have the capacity to potentiate the activity of antibiotics in Staphylococcus aureus small colony variants. Front Cell Infect Microbiol 7:280. https://doi.org/10.3389/fcimb.2017.00280
doi: 10.3389/fcimb.2017.00280
pubmed: 28690982
pmcid: 5479885
Rossato L, Arantes JP, Ribeiro SM, Simionatto S (2022) Antibacterial activity of gallium nitrate against polymyxin-resistant Klebsiella pneumoniae strains. Diagn Micr Infec Dis 102:1–4. https://doi-org.ez31.periodicos.capes.gov.br/ https://doi.org/10.1016/j.diagmicrobio.2021.115569
doi: 10.1016/j.diagmicrobio.2021.115569
Ross-Gillespie A, Weigert M, Brown SP, Kümmerli R (2014) Gallium-mediated siderophore quenching as an evolutionarily robust antibacterial treatment. Evol Med Public Health 2014:18–29. https://doi.org/10.1093/emph/eou003
doi: 10.1093/emph/eou003
pubmed: 24480613
pmcid: 3935367
Runci F, Bonchi C, Frangipani E, Visaggio D, Visca P (2017) Acinetobacter baumannii Biofilm formation in human serum and disruption by Gallium. Antimicrob Agents Chemother 61:1–8. https://doi.org/10.1128/AAC.01563-16
doi: 10.1128/AAC.01563-16
Rzhepishevska O, Ekstrand-Hammarström B, Popp M, Björn E, Bucht A, Sjöstedt A et al (2011) The antibacterial activity of Ga
doi: 10.1128/AAC.00386-11
pubmed: 21947396
pmcid: 3232821
Scaccaglia M, Rega M, Vescovi M, Pinelli S, Tegoni M, Bacci C et al (2022) Gallium(III)-pyridoxal thiosemicarbazone derivatives as nontoxic agents against Gram-negative bacteria. Metallomics 14:1–10. https://doi.org/10.1093/mtomcs/mfac070
doi: 10.1093/mtomcs/mfac070
Schalk IJ, Guillon L (2012) Fate of ferrisiderophores after import across bacterial outer membranes: different iron release strategies are observed in the cytoplasm or periplasm depending on the siderophore pathways. Amino Acids 44:1267–1277. https://doi.org/10.1007/s00726-013-1468-2
doi: 10.1007/s00726-013-1468-2
Sephton RG, Harris AW (1975) Brief communication: Gallium-67 citrate uptake by cultured tumor cells, stimulated by serum transferrin. J Natl Cancer Inst 54:1263–1266. https://doi.org/10.1093/jnci/54.5.1263
doi: 10.1093/jnci/54.5.1263
pubmed: 1168730
Song T, Zhao X, Shao Y, Guo M, Li C, Zhang W (2019) Gallium(III) Nitrate inhibits pathogenic Vibrio splendidus vs by interfering with the iron uptake pathway. J Microbiol Biotechn 29:973–983. https://doi.org/10.4014/jmb.1903.03008
doi: 10.4014/jmb.1903.03008
Thompson MG, Truong-Le V, Alamneh YA, Black CC, Anderl J, Honnold CL et al (2015) Evaluation of Gallium citrate formulations against a multidrug-resistant strain of Klebsiella pneumoniae in a murine wound model of infection. Antimicrob Agents Chemother 59:6484–6493. https://doi.org/10.1128/AAC.00882-15
doi: 10.1128/AAC.00882-15
pubmed: 26239978
pmcid: 4576086
Touati D (2000) Iron and oxidative stress in bacteria. Arch Biochem Biophys 373:1–6. https://doi.org/10.1006/abbi.1999.1518
doi: 10.1006/abbi.1999.1518
pubmed: 10620317
Tovar-García A, Angarita-Zapata V, Cazares A, Jasso-Chávez R, Belmont-Díaz J, Sanchez-Torres V et al (2019) Characterization of gallium resistance induced in a Pseudomonas aeruginosa cystic fibrosis isolate. Arch Microbiol 202:617–622. https://doi.org/10.1007/s00203-019-01777-y
doi: 10.1007/s00203-019-01777-y
pubmed: 31773196
Valappil SP, Higham SM (2014) Antibacterial effect of gallium and silver on Pseudomonas aeruginosa treated with gallium–silver–phosphate-based glasses. Bio-Med Mater Eng 24:1589–1594. https://doi.org/10.3233/BME-140963
doi: 10.3233/BME-140963
Valappil SP, Ready D, Neel EAA, Pickup DM, Chrzanowski W, O’Dell LA et al (2008) Antimicrobial gallium-doped phosphate-based glasses. Adv Funct Mater 18:732–741. https://doi.org/10.1002/adfm.200700931
doi: 10.1002/adfm.200700931
Visaggio D, Frangipani E, Hijazi S, Pirolo M, Leoni L, Rampioni G et al (2022) Variable susceptibility to Gallium compounds of major cystic fibrosis pathogens. ACS Infect Dis 8:78–85. https://doi.org/10.1021/acsinfecdis.1c00409
doi: 10.1021/acsinfecdis.1c00409
pubmed: 34965085
Wandersman C, Delepelaire P (2004) Bacterial iron sources: from siderophores to hemophores. Annu Rev Microbiol 58:611–647. https://doi.org/10.1146/annurev.micro.58.030603.123811
doi: 10.1146/annurev.micro.58.030603.123811
pubmed: 15487950
Wang Z, Li J, Benin BM, Yu B, Bunge SD, Abeydeera N et al (2021) Lipophilic Ga complex with broad-spectrum antimicrobial activity and the ability to overcome gallium resistance in both Pseudomonas aeruginosa and Staphylococcus aureus. J Med Chem 64:9381–8388. https://doi.org/10.1021/acs.jmedchem.1c00656
doi: 10.1021/acs.jmedchem.1c00656
pubmed: 34137262
Wang Y, Yang X, Zhang S, Ai J, Wang J, Chen J et al (2023) Comparative proteomics unveils the bacteriostatic mechanisms of Ga(III) on the regulation of metabolic pathways in Pseudomonas aeruginosa. J Proteom 289:105011. https://doi-org.ez31.periodicos.capes.gov.br/ https://doi.org/10.1016/j.jprot.2023.105011
doi: 10.1016/j.jprot.2023.105011
Weinberg ED (2009) Iron availability and infection. Biochim Biophys Acta Gen Subj 1790:600–605. https://doi.org/10.1016/j.bbagen.2008.07.002
doi: 10.1016/j.bbagen.2008.07.002
Xia W, Li N, Shan H, Lin Y, Yin F, Yu X et al (2021) Gallium porphyrin and gallium nitrate reduce the high vancomycin tolerance of MRSA biofilms by promoting extracellular DNA-dependent biofilm dispersion. ACS Infect Dis 7:2565–2582. https://doi.org/10.1021/acsinfecdis.1c00280
doi: 10.1021/acsinfecdis.1c00280
pubmed: 34346692
Xu Z, Zhao X, Chen X, Chen Z, Xia Z (2017) Antimicrobial effect of gallium nitrate against bacteria encountered in burn wound infections. RSC Adv 7:52266–52273. https://doi.org/10.1039/C7RA10265H
doi: 10.1039/C7RA10265H
Zemke AC, Madison CJ, Kasturiarachi N, Pearce LL, Peterson J (2020) Antimicrobial synergism toward Pseudomonas aeruginosa by Gallium(III) and inorganic nitrite. Front Microbiol 11:2113. https://doi.org/10.3389/fmicb.2020.02113
doi: 10.3389/fmicb.2020.02113
pubmed: 32983071
pmcid: 7487421
Zhu Y, Qiu Y, Chen R, Liao L (2015) The inhibition of Escherichia Coli biofilm formation by gallium nitrate-modified titanium. J Nanosci Nanotechnol 15:5605–5609. https://doi.org/10.1166/jnn.2015.10305
doi: 10.1166/jnn.2015.10305
pubmed: 26369125